Kalaris Therapeutics Insider Trades
NASDAQ: KLRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $6.18M
- Sales
- 1 · $12.87K
- Shares bought / sold
- 724.15K / 1.92K
- Net activity
- Net buying $6.2 million
Kalaris Therapeutics insider activity
Over the last 12 months, Kalaris Therapeutics insiders reported 7 transactions on SEC Form 4: 2 open-market purchases and 1 sale. Insiders bought $6.2 million and sold $12,869 worth of stock, for net insider buying of $6.2 million. The largest seller was Hagen Brett R, with $12,869 in reported sales.
The most recent filing shows AKKARAJU SRINIVAS & Samsara BioCapital, L.P. & Samsara BioCapital GP, LLC & Samsara Opportunity Fund, L.P. & Samsara Opportunity Fund GP, LLC (Director) buying 244,300 shares at $4.83 on May 20, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KLRS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
KLRS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 20, 2026 | AKKARAJU SRINIVAS & Samsara BioCapital, L.P. & Samsara BioCapital GP, LLC & Samsara Opportunity Fund, L.P. & Samsara Opportunity Fund GP, LLCDirector | other | 4,471 | — | Form 4 |
| May 20, 2026 | AKKARAJU SRINIVAS & Samsara BioCapital, L.P. & Samsara BioCapital GP, LLC & Samsara Opportunity Fund, L.P. & Samsara Opportunity Fund GP, LLCDirector | other | 14,937 | — | Form 4 |
| May 20, 2026 | AKKARAJU SRINIVAS & Samsara BioCapital, L.P. & Samsara BioCapital GP, LLC & Samsara Opportunity Fund, L.P. & Samsara Opportunity Fund GP, LLCDirector | other | 66,906 | — | Form 4 |
| May 20, 2026 | AKKARAJU SRINIVAS & Samsara BioCapital, L.P. & Samsara BioCapital GP, LLC & Samsara Opportunity Fund, L.P. & Samsara Opportunity Fund GP, LLCDirector | Buy | 244,300 | $1.18M | Form 4 |
| Mar 20, 2026 | Hagen Brett RChief Accounting Officer | Sale | 1,915 | $12.87K | Form 4 |
| Dec 22, 2025 | AKKARAJU SRINIVAS & Samsara Opportunity Fund, L.P. & Samsara Opportunity Fund GP, LLCDirector | Award | 1,500,000 | $15.00M | Form 4 |
| Dec 18, 2025 | AKKARAJU SRINIVAS & Samsara BioCapital, L.P. & Samsara BioCapital GP, LLC & Samsara Opportunity Fund, L.P. & Samsara Opportunity Fund GP, LLCDirector | Buy | 479,847 | $5.00M | Form 4 |
| Mar 26, 2025 | Hagen Brett RChief Accounting Officer | Sale | 907 | $8.14K | Form 4 |
| Mar 18, 2025 | Feinsod MatthewChief Medical Officer | Award | 4,030 | — | Form 4 |
| Mar 18, 2025 | PATEL SAMIR CHANDRAKANTDirector | Award | 100,800 | — | Form 4 |
| Mar 18, 2025 | PATEL SAMIR CHANDRAKANTDirector | Award | 252,000 | — | Form 4 |
| Mar 18, 2025 | AKKARAJU SRINIVASDirector | Award | 11,444,503 | — | Form 4 |
| Mar 18, 2025 | Ferrara NapoleoneDirector | Award | 504,000 | — | Form 4 |
| Feb 21, 2025 | Hagen Brett RChief Accounting Officer | Sale | 96 | $967.28 | Form 4 |
| Feb 21, 2025 | Miller EdwardGeneral Counsel | Sale | 106 | $1.07K | Form 4 |
| Feb 21, 2025 | Sinha VikasSee Remarks | Sale | 303 | $3.05K | Form 4 |
| Jan 23, 2025 | Miller EdwardGeneral Counsel | Sale | 5 | $49.70 | Form 4 |
| Jan 23, 2025 | Miller EdwardGeneral Counsel | Sale | 47 | $444.33 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4